In brief
- Governor Jenniffer González-Colón signed OE-2026-037 on 4 August to strengthen research and assess a possible pilot, not automatically authorize its launch.
- The order concerns emerging therapies and mentions compounds including ibogaine, psilocybin and MDMA in context; it does not establish active trials or outcomes.
- The Department of Health must build the regulatory infrastructure and coordinate with the Puerto Rico Veterans Advocate Office to explore veteran participation.
Puerto Rico’s OE-2026-037 requires assessment of whether an Emerging Therapies Clinical Research Pilot Program is advisable and feasible. The official PDF and PRFAA release distinguish assessment from operating authorization. The order does not permit routine clinical administration or prescribing of these therapies.
What Executive Order 2026-037 establishes
The order creates a Scientific and Regulatory Advisory Committee within Health to assess evidence, needs, feasibility and recommendations, not an operating pilot by itself. After recommendations, the governor would decide measures and, if adopted, require an implementation plan. Coordination with universities, hospitals and federal agencies is contemplated under applicable permissions; active trials or allocated funding are not established here.
Veterans and the broader context
The order provides coordination with the Veterans Advocate Office for orientation, referral and potential participation of resident veterans, subject to criteria and permissions. The 4 August release describes strengthening scientific and institutional capacity and mentions mental health, substance-use disorders and other conditions. These are policy objectives, not clinical efficacy or currently available access. This review does not verify industrial values or global pacemaker-production shares.
What this means
Assessment and a committee do not replace regulatory permissions, ethics review or state and federal law; sections 14 and 15 state this explicitly. This review does not establish actual committee constitution, allocated budget, later pilot authorization or enrollment. Implementation would be a separate stage needing its own evidence. For readers following policies on ibogaína and MDMA, this marks another piece in the evolving landscape of clinical research across the United States and its territories.
Source
- Marijuana Moment. Puerto Rico Governor Signs Psychedelics Executive Order. Marijuana Moment, August 5, 2026.
Educational content written from a harm reduction perspective and with respect for individual freedom. It is not a substitute for advice from a healthcare professional and is not intended to encourage or condemn any drug use.
